Aspirin resistance in patients with acute ischemic stroke (Q51038368)

27 March 2018

title

Aspirin resistance in patients with acute ischemic stroke (English)

1 reference

27 March 2018

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21509427

30 November 2024

author name string

Serkan Ozben

1

1 reference

27 March 2018

Beste Ozben

2

1 reference

27 March 2018

Azra Meryem Tanrikulu

3

1 reference

27 March 2018

Feriha Ozer

4

1 reference

27 March 2018

Tomris Ozben

5

1 reference

27 March 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21509427

30 November 2024

publication date

21 April 2011

1 reference

27 March 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00415-011-6052-7.pdf

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

http://link.springer.com/article/10.1007/s00415-011-6052-7/fulltext.html

30 November 2024

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

http://link.springer.com/content/pdf/10.1007/s00415-011-6052-7

30 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S00415-011-6052-7

30 November 2024

1 reference

27 March 2018

volume

258

1 reference

27 March 2018

issue

11

1 reference

27 March 2018

page(s)

1979-1986

1 reference

27 March 2018

Stroke epidemiology in the developing world

cites work

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Link between platelet activity and outcomes after an ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

The frequency of aspirin resistance and its risk factors in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Prevalence of aspirin resistance in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

The use of platelet function assays may help to determine appropriate antiplatelet treatment options in a patient with recurrent stroke on baby aspirin: against

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin resistance transient laboratory finding or important clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

A pilot study of resistance to aspirin in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Variable platelet response to aspirin in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin resistance in secondary stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin non-responder status in patients with recurrent cerebral ischemic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin resistance determined with PFA-100 does not predict new thrombotic events in patients with stable ischemic cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Biochemical aspirin resistance and recurrent lesions in patients with acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Resistance to antiplatelet substances--a real clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6052-7

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

21 January 2018

1 reference

12 December 2020

The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke

1 reference

12 December 2020

Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

1 reference

12 December 2020

Resistance to Aspirin and Thienopyridines in Diabetes Mellitus and Metabolic Syndrome

1 reference

12 December 2020

Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Resistance to acetylsalicylic acid in patients after ischemic stroke

1 reference

12 December 2020

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018